Skip to main content
Signal8

DEPTULA-HICKS DARLENE M

SEC insider (Form 3/4/5 filer). CIK 0001089409. Director at Aldeyra Therapeutics, Inc. (ALDX). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 9, 2026. Located in LEXINGTON, MA.

Companies DEPTULA-HICKS DARLENE M has filed insider reports for

  • Aldeyra Therapeutics, Inc. (ALDX): Director
DEPTULA-HICKS DARLENE M profile photo

DEPTULA-HICKS DARLENE M

CIK: 0001089409

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Aldeyra Therapeutics, Inc. logo
ALDX

Aldeyra Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Aldeyra Therapeutics, Inc. logo
    ALDX

    Aldeyra Therapeutics, Inc.

    Jun 9, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    84.6K shares-
  • Aldeyra Therapeutics, Inc. logo
    ALDX

    Aldeyra Therapeutics, Inc.

    Jun 9, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    9.8K shares-

1-2 of 2